Vaccination appointments can be booked using the Vaccine Clinic Finder.
Vaccination After COVID-19 Infection
COVID-19 vaccinations are recommended for people with a past history of COVID-19. The ATAGI clinical guidance on COVID-19 vaccination (Considerations for special populations> People with a past SARS-CoV-2 infection) recommends that vaccination is deferred by up to three months after acute infection with COVID-19. Patients who have experienced severe or prolonged symptoms (beyond three months) should be vaccinated on a case-by case basis after consultation with their GP.
COVID-19 and Flu Vaccination Timing
The ATAGI clinical guidance on COVID-19 vaccination (Considerations for special populations> Timing of administration of other vaccines) states that COVID-19 vaccines can be co-administered with an influenza vaccine.
COVID-19 Vaccination (Doseage, Age Range and Vaccine Information)
ATAGI has developed a factsheet which outlines recommended doses and vaccines for each age and vulnerability group. It is important to check each patient’s immunisation history before administering any vaccines. Patients immunisation history can be viewed through The Australian Immunisation Register (AIR), Clinician Vaccine Integrated Platform (CVIP) and My Health Record.
Adverse Event Following Immunisation Symptom Checker and Reporting
Vaccination providers are reminded to report concerns regarding a suspected adverse event following immunisation (AEFI). All uncommon, unexpected or serious AEFI, must be reported to the local Public Health Unit on 1300 066 055 or by email using the TGA AEFI case notification form. Additional information on investigation, management support and reporting requirements are available on the NSW Health COVID-19 vaccination website.
healthdirect has developed a diagnostic symptom checking tool for recipients of COVID-19 vaccinations and health professionals, to check for common symptoms of the currently available COVID-19 vaccines.
Identifying TTS in Vaccinated Patients
Patients presenting with symptoms of thrombosis with thrombocytopaenia syndrome (TTS) in the 4 to 30 days after vaccination should be managed as per the latest ACEM and THANZ advice. HealthPathways details the investigation and management of TTS under the Vaccination Procedure Pathway (navigate to Management and reporting of side-effects). The Department of Health has collated information for clinicians.
We recommend GPs stay up-to date with the latest COVID-19 advice and information from NSW Health, Dept of Health and the RACGP, as well as current clinical guidance from our HealthPathways' website.